Medicare Enrolled

Dr. Jason Suh, MD

Medical Oncology · Port Townsend, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
834 SHERIDAN ST, Port Townsend, WA 98368
3603443091
In practice since 2005 (20 years)
NPI: 1225024722 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Suh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Suh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Suh

Dr. Jason Suh is a medical oncology specialist in Port Townsend, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Suh performed 10,007 Medicare services across 575 unique beneficiaries.

Between the years covered by Open Payments, Dr. Suh received a total of $112,592 from 70 pharmaceutical and/or device companies across 504 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Suh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 12% volume in WA $112,592 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,007
Medicare services
Top 12% in WA for medical oncology
575
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~500 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
7,650 $0 $2
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
1,600 $6 $22
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
142 $8 $40
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $64 $255
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
138 $10 $55
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
133 $8 $20
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
69 $13 $70
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
54 $10 $61
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
28 $4 $20
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
26 $43 $206
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $101 $360
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
13 $121 $431
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
76.7% high complexity
16.5% medium
6.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$112,592
Total received (2018-2024)
Avg $16,085/year across 7 years
Top 9% in WA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
504
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85,473 (75.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,878 (19.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,241 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$685
2023
$2,984
2022
$9,070
2021
$14,304
2020
$5,644
2019
$28,289
2018
$51,617

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$221
AstraZeneca Pharmaceuticals LP
$160
Janssen Biotech, Inc.
$102
Daiichi Sankyo Inc.
$55
SOBI, INC
$47
Takeda Pharmaceuticals U.S.A., Inc.
$41
SpringWorks Therapeutics, Inc.
$30
Merck Sharp & Dohme LLC
$29
Top 3 companies account for 70.5% of 2024 payments
All-time payments by company (2018-2024) ›
Exelixis Inc.
$45,528
Merck Sharp & Dohme Corporation
$18,664
Incyte Corporation
$16,538
Novartis Pharmaceuticals Corporation
$7,677
PFIZER INC.
$5,887
AbbVie, Inc.
$3,619
Pharmacosmos Therapeutics Inc.
$2,673
GENZYME CORPORATION
$1,859
Karyopharm Therapeutics Inc.
$1,510
Celgene Corporation
$1,460
Seattle Genetics, Inc.
$1,189
Daiichi Sankyo Inc.
$744
Acceleron Pharma, Inc.
$668
Astellas Pharma US Inc
$512
E.R. Squibb & Sons, L.L.C.
$429
AstraZeneca Pharmaceuticals LP
$376
Janssen Biotech, Inc.
$330
Genentech USA, Inc.
$271
Global Blood Therapeutics, Inc.
$249
Lilly USA, LLC
$241
Seagen Inc.
$223
Pharmacyclics LLC, An AbbVie Company
$160
Eisai Inc.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$118
Rigel Pharmaceuticals, Inc.
$103
Amgen Inc.
$101
TESARO, Inc.
$82
Merck Sharp & Dohme LLC
$69
EMD Serono, Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$64
ABBVIE INC.
$49
DAVOL INC.
$47
SOBI, INC
$47
Jazz Pharmaceuticals Inc.
$46
Ipsen Biopharmaceuticals, Inc
$45
JAZZ PHARMACEUTICALS INC.
$43
Clovis Oncology, Inc.
$42
GlaxoSmithKline, LLC.
$39
Gilead Sciences, Inc.
$38
ADC Therapeutics America, Inc.
$36
EISAI INC.
$35
Kite Pharma, Inc.
$31
TerSera Therapeutics LLC
$30
SpringWorks Therapeutics, Inc.
$30
Pharmacyclics LLC, an AbbVie Company
$29
Mirati Therapeutics, Inc.
$27
PharmaEssentia USA Corporation
$27
Janssen Pharmaceuticals, Inc
$27
Aurobindo Pharma USA, Inc.
$26
Dova Pharmaceuticals
$24
Organon LLC
$24
Novo Nordisk Inc
$23
G1 Therapeutics, Inc.
$22
Innate Pharma, Inc
$21
Regeneron Healthcare Solutions, Inc.
$20
EUSA Pharma (US) LLC
$20
Apellis Pharmaceuticals, Inc.
$20
Sobi, Inc
$20
Myriad Genetic Laboratories, Inc.
$19
Midatech Pharma US Inc
$17
Acrotech Biopharma LLC
$16
PUMA BIOTECHNOLOGY, INC.
$16
Secura Bio, Inc.
$16
Kyowa Kirin, Inc.
$14
Alnylam Pharmaceuticals Inc.
$13
Mylan Institutional Inc.
$12
Medtronic USA, Inc.
$12
Shire North American Group Inc
$12
AMAG Pharmaceuticals, Inc.
$12
Boehringer Ingelheim Pharmaceuticals, Inc.
$11
Top 3 companies account for 71.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · Abraxane · Adcetris · Alecensa · Aliqopa · Avastin · BALVERSA · BESREMI · BOSULIF · Balversa · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · EMPLICITI · ENHERTU · ERLEADA · Empaveli · Enhertu · Erleada · FARESTON · FERAHEME · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · GIVLAARI · HEMADY · Humira · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Marqibo · NERLYNX · NINLARO · Neulasta · Nplate · OGSIVEO · OPDIVO · OSTEOCOOL RF ABLATION · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PHASIX · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · VONJO · VPRIV · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zuplenz · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for medical oncology in WA.

Looking for a medical oncology specialist in Port Townsend?
Compare medical oncologists in the Port Townsend area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
7
Per 100K population
21.0
County median income
$71,143
Nearest hospital
JEFFERSON HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Suh is a mixed practice specialist, with above-average Medicare volume (top 12% in WA), with speaking/promotional industry engagement in the top 9% of WA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Suh experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Suh performed 7,650 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Suh receive payments from pharmaceutical companies?
Yes. Dr. Suh received a total of $112,592 from 70 companies across 504 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Suh's costs compare to other medical oncologists in Port Townsend?
Dr. Suh's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Suh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →